Rivian Automotive, Inc. Class A (RIVN)

Rivian Automotive's stock has been pulled back to the lower part of its 52-week range, with the price at $13.71 and 21% of the way from its low to its high. Shares fell 2.14% in the latest session, while the stock is up 3.16% over one week. The stock sits 2.90% below its 50-day moving average and 10.78% below its 200-day average, so the trend reads as down even though the broader picture has improved since the October 29, 2026 report. That report gave the clearest recent evidence of progress. Rivian reported adjusted EPS of -$0.63 against a -$0.73 estimate, and the shares rose 6.20% in the next session. Revenue grew 38.30% year on year in the latest quarter. Whether that growth can narrow the losses is the question that will decide the stock's direction in the coming months.

Rivian's October 29, 2026 report was the most recent quarter and it beat expectations. Adjusted EPS came in at -$0.63 against an estimate of -$0.73, a beat of 13.70%, and the shares rose 6.20% in the next session. The beat came after a streak: the company has beaten EPS estimates in five of the last seven reports. Revenue grew 38.30% year on year in the latest quarter, far faster than the sector median of 7.2%.

A beat has not translated into a lasting gain. In three of the five beats, the shares fell in the following session, and the July 30, 2026 beat was followed by a 9.57% drop. Investors appear to be weighing the size of losses against the rate of revenue growth rather than the quarterly beat itself.

Rivian is not profitable. Its reported EPS over the last twelve months is -$2.26, so the P/E ratio is not meaningful. The price-to-sales ratio of 3.07 is 61.6% above the sector median of 1.9. Net profit margin is -45.88%, operating margin is -40.88%, and return on equity is -54.88%, all well below the sector's 12.4% median return on equity. Debt-to-equity of 0.95 is manageable, but the balance sheet depends on the company narrowing its losses.

Wall Street has become more positive recently. UBS upgraded the stock to Buy from Neutral on November 2, 2026, and Jefferies upgraded it to Buy from Hold on October 30, 2026. Needham kept its Buy rating and Cantor Fitzgerald kept its Neutral rating on the same date, while Citigroup started coverage at Neutral on September 14, 2026. Of 25 analysts, 14 rate the stock buy or strong buy, 6 hold and 5 sell or strong sell.

The base case is a stock that stays range-bound while it works back toward its moving averages. For the price to move higher in a sustained way, it would need to recover the 50-day average near $14.12 and then the 200-day average near $15.37, which would also signal that the downtrend is easing. Analysts are supportive: the median 12-month target of $18.00 sits 31.3% above the price, and the recent UBS and Jefferies upgrades moved the consensus to Buy. The bear case is that losses persist. Full-year analyst EPS estimates of -$2.33 for 2026 and -$2.29 for 2027 show that profitability is still far away. A quarter that misses estimates, or a drop below the 52-week low of $11.38, would weaken the case and could bring the lowest target of $10.00 into position. The stock's beta of 1.64 means it tends to move more than the broader market in either direction.

Support: the 20-day EMA at $13.18 is the nearest level below the price, and a fall would meet it first. Below that, the 52-week low at $11.38 is the next major floor, a level the stock has not closed below in the past year. Resistance: the 50-day SMA at $14.12 is the nearest level above the price and the first hurdle for any rally. The 200-day SMA at $15.37 comes next and marks the longer-term trend line. The 52-week high of $22.69 sits far above and would require a sustained rebound.